Rae R. Matsumoto

ORCID: 0000-0002-0558-1268
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacological Receptor Mechanisms and Effects
  • Receptor Mechanisms and Signaling
  • Neuroscience and Neuropharmacology Research
  • Neuropeptides and Animal Physiology
  • Nicotinic Acetylcholine Receptors Study
  • Neurotransmitter Receptor Influence on Behavior
  • Tryptophan and brain disorders
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Neurological disorders and treatments
  • Pain Mechanisms and Treatments
  • Treatment of Major Depression
  • Axial and Atropisomeric Chirality Synthesis
  • Innovations in Medical Education
  • Ion channel regulation and function
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Chemical synthesis and alkaloids
  • Glycogen Storage Diseases and Myoclonus
  • Marine Sponges and Natural Products
  • Epilepsy research and treatment
  • Computational Drug Discovery Methods
  • Innovative Teaching Methods
  • Sleep and Wakefulness Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cancer therapeutics and mechanisms
  • Traumatic Brain Injury Research

University of Hawaii at Hilo
2024

University of the Pacific
2024

West Virginia University
2011-2020

Touro University California
2014-2020

Chicago State University
2012

West Virginia University Hospitals
2012

University of South Florida
2012

Florida College
2012

University of Mississippi
2005-2011

University of Oklahoma Health Sciences Center
2000-2011

Haloperidol exhibits a high affinity for subclass of σ-"opiate" binding sites which have unique anatomic distribution and drug selectivity pattern. These differ from phencyclidine-sensitive σ-receptors are found in many brain areas involved the control movement. 1,3-Di-o-tolylguanidine (DTG), highly selective ligand haloperidol-sensitive σ-receptor, produced marked dystonia rats after micro injection into red nucleus, motor area rich this receptor. another σ-ligand [(+)-SKF 10,047] similar...

10.1212/wnl.38.6.961 article EN Neurology 1988-06-01

σ-1 receptor (S1R) radioligands have the potential to detect and monitor various neurological diseases. Herein we report synthesis, radiofluorination, evaluation of a new S1R ligand 6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo[d]thiazol-2(3H)-one ([(18)F]FTC-146, [(18)F]13). [(18)F]13 was synthesized by nucleophilic fluorination, affording product with >99% radiochemical purity (RCP) specific activity (SA) 2.6 ± 1.2 Ci/μmol (n = 13) at end synthesis (EOS). Positron emission tomography...

10.1021/jm300371c article EN Journal of Medicinal Chemistry 2012-08-01

Dextromethorphan is an antitussive with a high margin of safety that has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine. In addition binding NMDA receptors, dextromethorphan binds sigma-1 (σ1) which are believed be protein targets for potential new class medications. The purpose this study was determine whether elicits antidepressant-like effects and involvement σ1 receptors...

10.1371/journal.pone.0089985 article EN cc-by PLoS ONE 2014-02-28

To determine if Grit-S scores correlate with academic success in a doctor of pharmacy (PharmD) program, as well the pursuit and attainment postgraduate (residency or fellowship) training.

10.5688/ajpe81467 article EN American Journal of Pharmaceutical Education 2017-05-01
Coming Soon ...